These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 20177714)
1. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. Hongo M; Fujimoto K; J Gastroenterol; 2010 Jun; 45(6):618-24. PubMed ID: 20177714 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitis. Fujimoto K; Hongo M; Intern Med; 2011; 50(3):179-88. PubMed ID: 21297318 [TBL] [Abstract][Full Text] [Related]
3. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors. Gao W; Huang Y; Lu S; Li C Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768 [TBL] [Abstract][Full Text] [Related]
4. Risk Factors of Multiple Gastric Polyps according to the Histologic Classification: Prospective Observational Cohort Study. Jeong CY; Kim N; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH Korean J Gastroenterol; 2019 Jul; 74(1):17-29. PubMed ID: 31344769 [TBL] [Abstract][Full Text] [Related]
5. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Ally MR; Veerappan GR; Maydonovitch CL; Duncan TJ; Perry JL; Osgard EM; Wong RK Dig Dis Sci; 2009 Dec; 54(12):2617-22. PubMed ID: 19830554 [TBL] [Abstract][Full Text] [Related]
6. Fundic gland polyps are not induced by proton pump inhibitor therapy. Vieth M; Stolte M Am J Clin Pathol; 2001 Nov; 116(5):716-20. PubMed ID: 11710689 [TBL] [Abstract][Full Text] [Related]
7. Proton-pump inhibitor-induced fundic gland polyps with hematemesis. Tanaka M; Kataoka H; Yagi T Clin J Gastroenterol; 2019 Apr; 12(2):193-195. PubMed ID: 30251013 [TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy. Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247 [TBL] [Abstract][Full Text] [Related]
9. The association between duration of and indications for proton pump inhibitor use and risk of gastric polyps. Kroupa R; Pavlik T; Konecny S; Packova B; Dastych M; Pavlovsky Z; Dolina J Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):829-835. PubMed ID: 37395234 [TBL] [Abstract][Full Text] [Related]
10. No transformation of a fundic gland polyp with dysplasia into invasive carcinoma after 14 years of follow-up in a proton pump inhibitor-treated patient: A case report. Fukuda M; Ishigaki H; Ban H; Sugimoto M; Tanaka E; Yonemaru J; Kuroe S; Namura T; Matsubara A; Moritani S; Murakami K; Andoh A; Kushima R Pathol Int; 2018 Dec; 68(12):706-711. PubMed ID: 30511782 [TBL] [Abstract][Full Text] [Related]
11. Changes of Gastric Juice Microenvironment in Patients with Fundic Gland Polyp and Hyperplastic Polyp. Gao H; Chang L; Wang L; Zhou X; Wang N Pathobiology; 2021; 88(6):383-391. PubMed ID: 34500447 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for relapse of erosive GERD during long-term maintenance treatment with proton pump inhibitor: a prospective multicenter study in Japan. Fujimoto K; Hongo M; J Gastroenterol; 2010 Dec; 45(12):1193-200. PubMed ID: 20607308 [TBL] [Abstract][Full Text] [Related]
14. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772 [TBL] [Abstract][Full Text] [Related]
15. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration. Takeda T; Asaoka D; Tajima Y; Matsumoto K; Takeda N; Hiromoto T; Okubo S; Saito H; Aoyama T; Shibuya T; Sakamoto N; Hojo M; Osada T; Nagahara A; Yao T; Watanabe S Clin J Gastroenterol; 2017 Oct; 10(5):478-484. PubMed ID: 28660530 [TBL] [Abstract][Full Text] [Related]
16. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China. Cao H; Qu R; Zhang Z; Kong X; Wang S; Jiang K; Wang B Chin Med J (Engl); 2014; 127(7):1239-43. PubMed ID: 24709173 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study. Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387 [TBL] [Abstract][Full Text] [Related]
18. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Genta RM; Schuler CM; Robiou CI; Lash RH Clin Gastroenterol Hepatol; 2009 Aug; 7(8):849-54. PubMed ID: 19465154 [TBL] [Abstract][Full Text] [Related]
19. [Cystic polyposis of the stomach (fundic gland polyps)--relationship to the absence of Helicobacter pylori infection and a therapy with drugs suppressing gastric acidity]. Fixa B; Vanásek T; Volfová M; Nozicka J; Nozicka Z Cas Lek Cesk; 2012; 151(4):196-200. PubMed ID: 22679686 [TBL] [Abstract][Full Text] [Related]
20. Gastric fundic gland polyps: a clinico-pathological study from North West Tasmania. Samarasam I; Roberts-Thomson J; Brockwell D ANZ J Surg; 2009 Jun; 79(6):467-70. PubMed ID: 19566871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]